IGF::OT::IGF: MOBILE APPLICATION FOR PRESCRIPTION DRUG-ABUSE EDUCATION (MAPDE). POP: SEPTEMBER 18, 2015 - SEPTEMBER 17, 2016. N44DA-15-5581.

IGF::OT::IGF：处方药物滥用教育移动应用程序 (MAPDE)。

• 批准号: 9161971
• 负责人: GOUTAM SATAPATHY
• 金额: $ 50万
• 依托单位: INTELLIGENT AUTOMATION, INC.
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-18 至 2016-09-17
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9161971
• 关键词: Analgesics; Attitude; Behavioral; Collaborations; Communication; Contractor; Decision Making; Development; Feedback; Incentives; Institutional Review Boards; Intervention; Knowledge; Learning; Measures; Opioid; Outcome Measure; Pain Clinics; Patients; Phase; Pilot Projects; Procedures; Protocols documentation; Quality of life; Questionnaires; Recruitment Activity; Risk; Risk Reduction; Structure; Surveys; Testing; Visual; content retention; design; drug abuse education; follow-up; improved; medication compliance; mobile application; novel strategies; prescription drug abuse; primary care setting; skills; standard care; tool; usability

The proposed Phase II effort shall: Prepare the MAPDE application for use in primary care settings and long-term use by patients for the purpose of prescription misuse risk reduction. Develop the protocol and attain approvals for a pilot study to evaluate MAPDE over standard care in reducing risk of misuse and abuse. To conduct a pilot study and analyze the results for misuse risk measures, and find various indicators of the impact of MAPDE on misuse risk reduction in the primary care setting.

拟议的第二阶段工作应： 准备MAPDE应用程序用于初级保健环境和患者长期使用，以降低处方误用风险。 制定方案并获得试点研究的批准，以评估MAPDE在降低误用和滥用风险方面优于标准治疗。 开展试点研究，分析误用风险措施的结果，并找到MAPDE对初级保健环境中误用风险降低的影响的各种指标。